Lunch Talk: Flipping Research on Its Head with Dr. David Fajgenbaum

Monday, April 13, 2015 - 1:00pm

Dr. David Fajgenbaum, MD, MSc, is Adjunct Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Pennsylvania, the co-founder and Executive Director for the Castleman Disease Collaborative Network (CDCN), and a 2015 member of Forbes Magazine's 30 Under 30 Healthcare list. Dr. Fajgenbaum co-founded the CDCN in 2012 to accelerate research and treatments for Castleman disease through global collaboration, strategic investment in high impact research, patient engagement, and partnership with industry and academia. His recent publication in Blood initiated a paradigm shift in the model of Castleman disease pathogenesis and introduced a new classification system. Dr. Fajgenbaum is also interested in the application of business principles to accelerate biomedical research.